At Abarca, we are constantly pursuing new and better ways to deliver greater value and accountability for plans and members, and we see great opportunities in drug contracting.
We’ve already announced innovative agreements with Amgen and Biogen, and are close to announcing additional contracts that will ensure our clients receive the value they expect, and members experience the intended outcomes.
That’s why we’re excited to share our thinking and approach at CBI’s Outcomes-Based Contracting Summit in fall 2018. Abarca Vice President of Rebates and Pricing Strategies Samir Mistry will discuss our strategy, challenges, and overall value proposition.
Other speakers on combating challenges of value-based agreements include University of Washington Medicine Health System, BeiGene, and Bristol-Myers Squibb. Learn more about the CBI Outcomes-Based Contracting Summit.